geneUp	minExonUp	maxExonUp	geneDown	minExonDown	maxExonDown	source	sourceEvent	sourceUrls	studyNctId	studyTitle	countriesOfStudy	treatment	sourceRelevantTreatmentApproaches	relevantTreatmentApproaches	applicableCancerType	applicableDoid	blacklistCancerTypes	level	direction	evidenceUrls
EGFR	1	2	EGFR	8	9	VICC_CIVIC	fusion	http				Osimertinib			Lung Cancer	X		A	RESPONSIVE	http,http
EML4			ALK			VICC_CIVIC	fusion	http				Crizotinib			Lung Cancer	X		A	RESPONSIVE	http,http
PCM1			JAK2			VICC_CGI	fusion	http				Ruxolitinib			Leukemia	X		B	RESPONSIVE	http,http